STRS Ohio’s Neuronetics STIM Stock Holding History

STRS Ohio’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,800	Closed	-$27K	–	2204
2019 Q1	$27K	Hold	1,800	–	–	﹤0.01%	1947
2018 Q4	$34K	Hold	1,800	–	–	﹤0.01%	1931
2018 Q3	$57K	Buy	+1,800	New	+$54.7K	﹤0.01%	1929

Other funds holding STIM

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

STRS Ohio's STIM Position: Q2 2019 in Review

STRS Ohio sold out of Neuronetics (STIM) in Q2 2019, closing a stake of 1,800 shares — an estimated $27K sold.

STRS Ohio first reported a position in STIM in Q3 2018 and held it in 3 quarters. The position peaked at $57K in Q3 2018. 59 funds tracked by Wall St. Rank hold STIM as of Q2 2019.

STRS Ohio reported no remaining Neuronetics position as of Q2 2019 after selling out during the quarter.
STRS Ohio sold 1,800 Neuronetics shares in Q2 2019, an estimated $27K.
STRS Ohio first reported a position in Neuronetics in Q3 2018 and held it in 3 quarters.
STRS Ohio's Neuronetics position peaked at $57K in Q3 2018.
59 funds tracked by Wall St. Rank held Neuronetics as of Q2 2019.

Based on STRS Ohio's 13F filing for Q2 2019, filed 25 Jul 2019.